ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GDR Genedrive Plc

3.875
-0.10 (-2.52%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Genedrive Investors - GDR

Genedrive Investors - GDR

Share Name Share Symbol Market Stock Type
Genedrive Plc GDR London Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.10 -2.52% 3.875 16:26:45
Open Price Low Price High Price Close Price Previous Close
4.025 3.725 4.625 3.875 3.975
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Top Investor Posts

Top Posts
Posted at 13/7/2024 07:24 by john henry
Z1CO you obviously didnt understand the content of my post.

I said the share price would retest the break area around 2p it actually retested 2.025p before moving.

where in fact ive added further.

Technically ive called this correct.

However as your not a Technical chartist i dont expect you to understand the term TAG

The move Higher above 2p is investors getting on board in anticipation of a positive NICE review therefore the Market( Investors) are discounting positive news.

Imho Investors will discount to around 3p plus until actual news appears.
Posted at 11/7/2024 17:05 by kingston78
The number of shares in issue is not a problem. It is a fallacy to argue that it takes time to churn those shares. Let's flip the argument to say that if PH had kept its shares, and there was demand from existing and new investors for more shares because they saw GDR as a good investment now, MMs would be short of stock and they would raise the price to attract sellers.

Likewise even if PH were selling the shares and if and only if there was sufficient demand investors would soak up the persistent sale by PH so that the share price would be on an uptrend. There must have been both persistent selling as well as doubters around to reduce demand. What I don't understand is that why there are so many doubters for many of us see as a promising business. I suppose it takes an opposite view to make a market.
Posted at 01/7/2024 12:06 by kingston78
Buyers and sellers are playing a waiting game.
Some sellers want a small and quick profit. They actually want the share price to go up in order for them to sell into strength.
Some buyers want to buy at a low price. They actually want the share price to go down.
Existing holders, especially those who will hold for a medium to long term, want the share price to go up and up.
Overhang of shares owned by Peel Hunt and its nominee investors is dragging the share price down. Once this is cleared the share price will gradually rise and then there comes a quantum leap on good news.
If you look at the historical share chart you know how much higher the share price was, and its products had not yet been approved by NICE. Investors bought on speculation. I would call this "illusion".
We should hang on for a month when NICE formally announces its approval and recommendation. GDR will go into an overdrive. This is what I call "reality".
Sometimes illusion is stronger than reality, but reality always prevails in the long term. This is a 5 bagger at least and a 10 bagger possible.
Just look at Sareum (from 10 p to 50 p in three months)or the Yu Group (Yu was at 95 p some years ago when I bought in, and how it has gone as high as £20 a share).
Posted at 22/6/2024 10:57 by john henry
High volume trading week

102M shares sold by the MMs Hence 102M purchased by Investors

38M purchased by the MMs. Hence 38M sold by Investors.

Just a Note Peel Hunt have been on the Offer and selling all week.

When PH move decisively away from the Offer share price should rocket higher.

AIMHO
Posted at 19/6/2024 18:33 by hazl
Petersinthemarket shows extreme ignorance.

I and various other investors, saved this company from going under, I am absolutely certain, by making it more visible on the threads and revealing the very good work Genedrive do.

Thank you.... you know who you are.

Without our attention and sacrificing our time, I think it might not have been able to get this placing away.

We all know the ones that relentlessly talked it down, so that the only thing the company could hope for, was a placing at an extreme low.

We also witnessed them using the same information we posted, as a lure to bring the new investors in as soon as they bought shed loads, at 1.5p.

Suddenly the company wasn't a dead loss, according to their posts, but something of value.
Funny that.

I wish all the posters well, who remain here (except the one formerly alluded to)
and true to my word I have my shares and also bought more.

The decider will be NICE and their input as to what happens to the share price in the short term.
But I encourage anyone new to be aware that when a poster has been hypocritical once, he is likely to be so again and I bet he has already sold some of his 1.5p shares today.
Finally, it doesn't matter what others do, do what suits you.
I will wait for the NICE decision and wish long termers here well and Z1CO who calls it, how he sees it as far as I have been aware.

IMO

Good luck GDR you deserve it!
Posted at 18/6/2024 09:57 by kingston78
The most exciting time is soon approaching for this company. Trading in the shares in GDR will be massive. That will generate more interest in the company. It is true that some existing shareholders will sell (hopefully at a profit), but equally new investors and some existing investors will be loading up. Market makers love huge volume because they make lots of money from the spread. MM actually want to mark up the share price to generate more demand.

Mark my word. It will not be long before the share price will exceed 2 p. Once that barrier is broken there is sometimes what I call a quantum leap, jumping to 5 p in my opinion (back to the level before its most recent decline).
Posted at 17/5/2024 14:33 by jaknife
kingston78,

"There are always insiders or people who know something about it, short selling to drive the price down."

The only problem with that thesis is that there is exactly 0% short interest in Genedrive:



There is no material short interest, which shouldn't be a surprise because:

1. Genedrive is a tiny market cap and hedge funds short large companies, not small ones.

2. There is negligible institutional interest in Genedrive! Something like 97% of the stock is held by retail investors and, as every well-informed investor will tell you, it is impossible to borrow shares from ordinary retail investors in the UK - you can only borrow stock from professional institutional investors!

So given that we've discounted shorters that leaves the real culprits of the share price decline as ... the sensible sane long investors who long ago realised what a pile of sh-one-t Genedrive was and sold their shares!

JakNife
Posted at 14/5/2024 09:49 by hazl
I will leave it at that.
It is upto people do to do what they think is best .
It is a risk of losing your money either way.
They have aready raised some which at least is something but need retail investors as well.
That is why the shorters still pester, I imagine.


'The Company announces that it has successfully placed 138,799,994 Placing Shares at the Issue Price with investors made up as to 11,173,994 Firm Placing Shares and 127,626,000 Conditional Placing Shares resulting in gross proceeds of approximately £2.1 million.

As previously announced unless the Fundraising, in aggregate, raises gross proceeds of not less than £6.0 million (the "Minimum Proceeds") it will not proceed other than the Firm Placing (should that element of the Fundraising become unconditional). Accordingly, the Company needs to raise a minimum of approximately £3.9 million (gross) from the REX Offer and the Open Offer so that the Minimum Proceeds are raised.'


IMO
Posted at 24/9/2023 09:58 by hazl
At last my opinion on little tech and biotech companies has been vindicated.
Thank you so much Jim Armitage from the Sunday Times for your excellent article!

I couldn't understand why time after time our UK small companies were not supported and if viable would be bought up by the American companies.

Far,far,be it just about patents!


From the Times today.

'UK life sciences teams are every bit as skilled and successful at creating such breakthroughs as their peers in the US universities of Stanford and MIT,or China.

For the most life-enhancing medicines that result,huge wealth is to be made for investors'.


Now here's the rub.


'European biotech gathers in London in November for annual Jeffries Healthcare conference, the venue will be packed with bankers and fund managers hunting for the most promising UK Science to invest in.'
'The trouble is most of the moneymen and women will be American
rather than British .'

What is Britain playing at?! My comment.


'The US has a sophisticated financial infrastructure for every stage of the development process'.

'They then use a network of close contacts in well funded capital firms to fund them through the laboratory stage'.' Then when the science is proven in the test tube, bigger investors - pension funds ,endowments and the like - write their cheques for tens or hundreds of millions of dollars needed.'

'In Britain ,while we have well-advised venture capitalists for the early stage work, the big, institutional investors are far behind'.
'So when it comes to the scaling up stage ,US investors swoop in to take the spoils, usually going on to launch the IPO in the US.'

I have acknowledged people's expertise here, but I have seen many things that have dismayed me over the years, as I have centred around these small innovative companies,and you could say I have developed some expertise of sorts.

It is not always AIM companies themselves that are to blame.

'For the most life enhancing medicines that result, huge wealth is to be made for investors'.

I repeat ....
'That is why the cream of European biotech gathers in London in November for the annual Jeffries Conference.'

So what happens now?
It seems there is some hope.
The government has said that it was making nine UK pension funds put 5% of their funds into private businesses.#
The aim is to steer as much as 75 billion pounds into start ups.


Better late than never!

Interesting that Genedrive has been given a grant.


Anyone that colludes with this system, by bets against our little London companies, ought to feel ashamed of themselves....playing right into the American market in my opinion!


IMO
Posted at 24/9/2023 09:35 by pugugly
Can anyone do the sums on the financing to estimate how many new shares will be required to be issued if the Investor has to exercise the option below??
Possibly one for Terminator to exercise his/her/its brain power.

"-- If the Investors have disposed of all the Initial Placing Shares and amounts remain outstanding, the Investors can issue subscription notices to the Company to receive further subscription shares. The subscription price payable by the Investors will be applied to reduce the amounts of the prepayment principal outstanding pursuant to the Facility. The number of shares to be issued would be calculated at the lower of the Fixed Premium Placing Price and the Adjusted Placing Price . This price is reset in the event that the Company issues further shares at a price less than the Fixed Premium Placing Price, to the lower subscription price.
-- The term of the Facility is two years.
-- The Facility automatically terminates once the Facility is redeemed in full
-- The Investors will also be granted a number of warrants equal to 40% of each drawdown divided by the Reference Price. The exercise price of the warrants payable to the Company will be 140% of the Reference Price.

Your Recent History

Delayed Upgrade Clock